2m 2m 2m 2m 2m 2m 2m
VIR BIOTECHNOLOG (VIR)
NASDAQ
$10.12+$0.55 (+5.79%)
Price as of Jun 23, 2026 7:52 PM EDT- $1.6BMarket Cap
- 89.50%1-Year Change
- BiotechnologyIndustry
VIR BIOTECHNOLOG (VIR)
$10.12+$0.55 (+5.79%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 63.1M -14.92% | 74.2M -13.90% | 86.2M -94.67% | 1.6B +47.51% | |
Cost of Revenue | 26,000 -96.92% | 845,000 -69.44% | 2.8M -98.11% | 146.3M +122.15% | |
Gross Profit | 63.1M -13.98% | 73.4M -12.05% | 83.4M -94.32% | 1.5B +42.73% | |
Sales and Marketing Expense | 92.1M -22.65% | 119.0M -33.15% | 178.0M +10.07% | 161.8M +0.60% | |
Research and Development Expense | -456.0M -9.98% | -506.5M -14.10% | -589.7M +24.23% | -474.6M +5.95% | |
Depreciation and Amortization Expense | 11.7M -19.77% | 14.6M +2,641.81% | 531,000 -0.19% | 532,000 -0.19% | |
Total Operating Expenses | 547.9M -17.16% | 661.4M -14.16% | 770.5M -1.56% | 782.7M +16.02% | |
Operating Profit | -479.3M -18.37% | -587.2M -14.20% | -684.3M -182.14% | 833.1M +98.00% | |
Interest Income | 40.2M -43.97% | 71.8M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 40.2M -43.97% | 71.8M N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 41.6M -35.13% | 64.1M +14.17% | 56.1M +171.22% | -78.8M -161.05% | |
Income before Taxes | -437.8M -16.31% | -523.1M -16.73% | -628.2M -183.28% | 754.3M +37.19% | |
Income Taxes | 217,000 +118.95% | -1.1M -91.24% | -13.1M -105.48% | 238.4M +1,023.78% | |
Extraordinary Items | 25.3M 0.00% | 25.3M +228.57% | 7.7M N/A | N/A N/A | |
Net Income | -438.0M -16.09% | -522.0M -15.14% | -615.1M -219.25% | 515.8M -2.41% | |
Net Income from Continuing Operations Applicable to Common | -437.8M -16.31% | -523.1M -14.95% | -615.1M -181.54% | 754.3M +37.19% | |
Basic EPS and Net Income | -3.16 -17.49% | -3.83 -16.56% | -4.59 -217.99% | 3.89 -4.42% | |
Diluted EPS and Net Income | -3.16 -17.49% | -3.83 -16.56% | -4.59 -219.84% | 3.83 -3.28% | |
Basic Weighted Average Shares | 138.5M +1.67% | 136.2M +1.58% | 134.1M +1.15% | 132.6M +2.10% | |
Diluted Weighted Average Shares | 138.5M +1.67% | 136.2M +1.58% | 134.1M -0.50% | 134.8M +1.03% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 232.2M +4.14% | 222.9M -7.71% | 241.6M -71.53% | 848.6M +143.99% | |
Short-Term Investments | 228.8M -66.26% | 678.1M -46.65% | 1.3B -16.47% | 1.5B +600.57% | |
Cash and Cash Equivalents and Short-Term Investments | 460.9M -48.84% | 901.0M -40.43% | 1.5B -36.18% | 2.4B +319.50% | |
Total Current Assets | 514.1M -50.69% | 1.0B -34.36% | 1.6B -36.95% | 2.5B +61.19% | |
Accumulated Depreciation | 47.2M +28.20% | 36.8M +8.52% | 33.9M +63.41% | 20.7M +43.13% | |
Property and Plant and Equipment and Net | 55.6M -11.97% | 63.2M -34.20% | 96.0M -9.08% | 105.6M +146.55% | |
Total Long-Term Assets | 24.7M +104.85% | 12.1M -2.84% | 12.4M -14.83% | 14.6M +425.05% | |
Total Assets | 1.0B -28.31% | 1.4B -27.11% | 1.9B -31.51% | 2.8B +43.38% | |
Income Taxes Payable | N/A N/A | N/A N/A | 149,000 -95.42% | 3.3M -82.36% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 92.8M -22.44% | 119.7M -31.78% | 175.4M -65.68% | 511.0M +49.76% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 21.6M +48.03% | 14.6M +2.24% | 14.3M +81.35% | 7.9M +209.53% | |
Total Liabilities | 237.5M -4.38% | 248.4M -24.45% | 328.8M -54.59% | 724.1M +38.61% | |
Retained Earnings | -1.2B +57.65% | -759.8M +219.47% | -237.8M -163.04% | 377.2M +372.18% | |
Total Stockholders Equity | 765.3M -33.48% | 1.2B -27.66% | 1.6B -23.47% | 2.1B +45.12% | |
Total Shares Outstanding | 139.5M +1.84% | 137.0M +1.62% | 134.8M +1.16% | 133.2M +1.58% | |
Cash Flow | |||||
Cash from Operating Activities | -391.8M -12.23% | -446.4M -42.69% | -778.8M -146.82% | 1.7B +3,595.04% | |
Capital Expenditures | 4.8M -33.82% | 7.3M -66.16% | 21.6M -68.29% | 68.0M +211.81% | |
Cash from Investing Activities | 310.4M -37.85% | 499.4M +203.33% | 164.6M +113.79% | -1.2B +747.54% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 3.8M -13.74% | 4.4M -41.34% | 7.5M -78.48% | 34.8M -65.35% | |
Financials Ratio | |||||
Gross Margin | 99.96% +1.11% | 98.86% +2.14% | 96.79% +6.43% | 90.94% -3.24% | |
Operating Margin | -759.27% -4.04% | -791.27% -0.35% | -794.04% -1,640.10% | 51.56% +34.23% | |
Return on Assets | -36.47% +15.93% | -31.46% +20.74% | -26.06% -220.14% | 21.69% -41.05% | |
Return on Equity | -45.73% +20.05% | -38.09% +13.58% | -33.54% -214.10% | 29.39% -40.26% | |
Revenue Growth | -14.92% +7.41% | -13.90% -85.32% | -94.67% -299.27% | 47.51% -96.44% | |
Current Ratio | 5.54 -36.42% | 8.71 -3.79% | 9.05 +83.68% | 4.93 +7.63% | |
Cash Ratio | 2.50 +34.27% | 1.86 +35.28% | 1.38 -17.07% | 1.66 +62.92% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow